Articles tagged with Embryonic Stem Cells
The new method uses transcription factors to promote cell differentiation and maturation, producing nerve cells with functional characteristics similar to mature cells found in the body. This breakthrough could accelerate the development of new drugs and stem cell-based regenerative medicine for age-related diseases such as Parkinson's...
Scientists at the Centre for Genomic Regulation have made a breakthrough in understanding cell reprogramming by identifying the crucial role of the Wnt signaling pathway. By inhibiting this pathway, they increased the efficiency of the process and obtained more pluripotent cells.
Researchers have successfully reprogrammed adult patient cells into pluripotent stem cells using nuclear transfer, a breakthrough that could lead to personalized genetic therapy and cell replacement.
Researchers at Stanford University and Montana State University have successfully transplanted stem cells from infertile men into mice, resulting in the formation of primordial germ cells. The study provides a valuable model for understanding the earliest stages of human reproduction, which varies significantly from that of common labo...
Researchers successfully restored damaged heart muscles in monkeys using human embryonic stem cells, suggesting a promising approach for human treatment. The therapy regenerated 40% of the damaged heart tissue and improved cardiac function in some treated animals, but also raised concerns about arrhythmias.
Researchers have made a significant breakthrough in understanding how cardiac progenitor cells, responsible for building mouse hearts, can renew themselves. This discovery may pave the way for using these cells to repair damaged heart tissue and even grow new heart tissue for transplantation.
Researchers at NYSCF and Columbia University Medical Center have successfully created the first disease-specific human embryonic stem cell line using somatic cell nuclear transfer (SCNT). The achievement marks a major step towards developing personalized cell therapies for life-threatening diseases like type 1 diabetes. By reprogrammin...
Researchers at the University of Cambridge have discovered that embryonic stem cell nuclei exhibit auxeticity, a property allowing them to 'sponge up' essential materials. This unusual behavior has potential applications in soundproofing, super-absorbent sponges and bulletproof vests.
Human embryonic stem cells grown on soft, synthetic micropost carpets made of polydimethylsiloxane turn into nerve cells faster and more often than those grown on traditional plates or rigid carpets. This breakthrough could advance stem cell therapies for diseases such as amyotrophic lateral sclerosis.
Researchers isolated very small embryonic-like stem cells from human adult tissues and demonstrated their ability to differentiate into multiple cell types, including bone, neurons, and connective tissue. The study provides evidence that these multipotent stem cells could be used for regenerative therapies.
Researchers developed SIF-seq to identify mammalian enhancers, which amplify specific gene expression, and validate ChIP-seq results. The technique offers a higher-throughput functional assay for various cell types and developmental contexts.
Researchers at UC Davis successfully coax laboratory cultures of human stem cells into the specialized, unique cells needed to repair a patient's defective or diseased bladder. The breakthrough provides a pathway to regenerate replacement bladder tissue for patients whose bladders are too small or do not function properly.
Scientists at the University of Washington have successfully created a line of human embryonic stem cells that can develop into various tissues. The new 'naive' cells retain their natural ability to differentiate into all types of human cells without artificial genes, opening up possibilities for regenerative medicine and transplantation.
Researchers discovered that an RNA binding mechanism causes fragile X syndrome to occur when there are 200 or more CGG repeats in the gene. A drug that blocks this silencing mechanism can prevent fragile X syndrome, suggesting similar therapy is possible for other diseases.
A team of researchers found that some cells exhibit random monoallelic gene expression during development, which can affect protein production and potentially lead to diseases. The phenomenon is more common in mature cell types than stem cell precursors.
Researchers from the University of Cambridge have discovered a way to study and film embryo development during implantation, revealing a 'rosette' structure that challenges current understanding. This breakthrough could improve IVF success rates and advance regenerative medicine.
Researchers at Gladstone Institutes develop technique to replenish destroyed ß-cells in animal models, showing promise for a permanent solution to manage type 1 diabetes. The study uses regenerative medicine to transform skin cells into insulin-producing pancreas cells.
Researchers have identified the Brg1 protein as a key regulator of genes involved in maintaining embryonic stem cell pluripotency. This discovery has important implications for cellular reprogramming technologies, including methods to reprogram adult somatic cells.
A new study has developed a scaffold of carbon nanotubes that allows for the safe growth of human stem cells in the laboratory. This breakthrough technology could pave the way for revolutionary treatments for diseases such as Parkinson's, diabetes, and heart disease.
A new method allows for large-scale generation of high-quality human embryonic stem cells from excess IVF embryos, increasing the supply for potential therapies. This breakthrough method enables production of stem cells without destroying embryos, making it a significant step forward for stem cell research.
Researchers at Johns Hopkins Medicine have developed human induced-pluripotent stem cells that can repair damaged retinal vascular tissue in mice without using viruses. These non-viral, human retinal iPSCs were grown using a safer method and showed comparable ability to human embryonic-derived iPSCs.
Researchers at the University of Cambridge have created a technique that can pinpoint the factors driving cell differentiation, including previously unidentified genes. The method uses haploid embryonic stem cells to uncover how cell differentiation works.
Researchers developed a new way to study bone disorders and bone growth using stem cells from patients with a rare genetic bone disease. The approach identified a cellular mechanism driving abnormal bone growth and found chemicals that can slow it, potentially guiding future drug development.
Researchers at UC San Diego have developed a humanized mouse model that can prevent the immune system from rejecting human embryonic stem cells. This breakthrough allows for potential use in developing stem cell therapies and understanding how tumors evade the immune system.
Scientists have successfully differentiated human pluripotent stem cells into kidney tubular cells using a specific cocktail of chemicals. The resulting cells expressed key markers and could form functional tubules when transplanted into adult mouse kidneys.
Researchers at CNIO demonstrate that cells from various tissues can be converted into embryonic stem cells using Shinya Yamanaka's technique, exhibiting higher plasticity than existing iPSCs.
Researchers at UC Irvine's Institute for Memory Impairments and Neurological Disorders have received a grant to develop and study patient-derived stem cell lines. The UCI MIND team will create up to 40 sets of induced pluripotent stem cells to explore the biology of Alzheimer's disease and test novel therapeutic approaches.
A Kyoto University research team developed a method to produce erythrocyte progenitor cells with almost unlimited replication ability in vitro. These cells were successfully differentiated into mature erythrocytes with oxygen-carrying capacity, showing potential for a reliable transfusion system.
Researchers at MIT and Brigham and Women's Hospital have successfully grown unlimited quantities of intestinal stem cells that can differentiate into mature cells. These cells hold promise for treating diseases such as ulcerative colitis and could be used for drug development and testing.
Researchers have successfully transformed human stem cells into functional lung and airway cells, opening up new possibilities for regenerative medicine. The breakthrough has significant implications for modeling lung diseases, screening drugs, and studying human lung development.
Researchers at University of Copenhagen and University of Edinburgh identified 53 genes that regulate cell adhesion in embryonic stem cells. This new insight will enable scientists to maintain stem cells more effectively and efficiently manipulate adult cells to revert to a stem cell-like stage.
Scientists at Boston Children's Hospital discover that enhancing cell metabolism is key to tissue repair, opening new avenues for regenerative treatments. They found that reactivating the dormant Lin28a gene enhances mitochondrial metabolism, leading to enhanced wound healing and regeneration.
Researchers at the Weizmann Institute of Science have successfully created induced pluripotent stem cells (iPS cells) that can be kept in a pristine state, paving the way for growing transplant organs to order. The breakthrough enables the production of 'humanized' mouse models containing human-derived tissues.
Researchers at USC have identified a novel way of culturing human ESCs by focusing on the Wnt/beta-catenin signaling pathway. This discovery reveals the important role of Tfcp2l1 in communicating to ESCs that they should self-renew, offering promise for developing stem cell-based therapies for diseases such as Parkinson's and spinal co...
Scientists at Stanford University School of Medicine have developed a fast and efficient way to turn fat cells extracted from routine liposuction into liver cells. This method, which uses spherical culture, produces human liver-like cells that flourish inside mice bodies without signs of being tumorogenic.
Bioengineers at the University of California, Berkeley, have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage. The researchers found a four-fold increase in the number of cells that reverted back to an embryonic-like state compared with cells grown on a flat surface.
Research reveals super-enhancers play crucial roles in both healthy cell regulation and disease, with mutations associated with diseases occurring in these regions. The discovery may lead to the development of personalized medicine approaches for cancer treatment and diagnosis.
A single gene mutation in the HPRT1 gene is linked to Lesch-Nyhan syndrome and other neurological disorders such as Alzheimer
A laboratory study at the University of Michigan has shown promising results in regenerating cardiac birth defects using amniotic stem cells. The researchers believe this approach could one day help thousands of babies born each year with congenital heart defects.
Experts recommend approaches to standardize quality control, develop cost-effective sharing models, and create large-scale libraries of iPSC lines. These efforts aim to tap into the potential of iPSCs for drug screening, disease modeling, and medical treatments.
Researchers have identified a link between mitochondrial development and the origins of some congenital heart defects. Mitochondria orchestrate events that determine a cell's future, including whether it becomes heart muscle cells.
Researchers discovered the critical role of retinoic acid signaling pathway in forming blood-forming stem cells. The study used mouse models to demonstrate that disrupting this pathway eliminates blood-forming stem cells, while activating it increases their numbers.
Researchers find removing MBD3 protein increases efficiency of stem cell reprogramming from 1% to 100%, allowing for faster production of cells for medical use. This breakthrough provides a deeper understanding of embryonic development and could advance treatment of various diseases.
Researchers from CNIO successfully produce embryonic stem cells directly from living adult mice, exhibiting primitive totipotent characteristics and broader differentiation capacity than in vitro-derived cells.
Scientists at A*STAR's Genome Institute of Singapore have discovered a protein mediator SON plays a critical role in the health and proper functioning of human embryonic stem cells. The study found that splicing factors, including SON, are key regulators of hESC maintenance.
Cardiac muscle cells can be purified using molecular beacons, enabling their use in treating heart diseases. The technique has broad applications across regenerative medicine.
The study reveals that the protein complex Mll2 is responsible for implementing activating histone marks on 'poised' genes, but its loss has little effect on developmental gene activation during differentiation. This suggests a more complex understanding of histone modification patterns in embryonic and cancer cells.
The new approach has broad applicability for the successful production of iPSCs for use in human stem cell studies and eventual cell therapies. The method is highly reproducible, efficient, non-integrative, and works on both young and old human cells.
Despite claims of their existence, Stanford researchers failed to identify pluripotent 'embryonic-like' cells in the bone marrow of adult mice. The study's findings contradict previous research and highlight the need for rigorous validation of scientific results.
A new study published in Stem Cell Reports found no evidence of the existence of very small embryonic-like stem cells (VSELs), which could have been used for regenerative medicine. The researchers refuted claims of VSELs' potential, calling into question current plans for a clinical trial.
Researchers at the Salk Institute have developed a more versatile method for creating induced pluripotent stem cells (iPSCs), which can be tailored to individual patients. By adjusting the balance of genes required for differentiation, scientists can create iPSCs with greater flexibility and potential for clinical application.
Researchers at Indiana University have successfully created the inner ear from stem cells using a three-dimensional cell culture method. The discovery provides insights into the sensory organ's developmental process and offers potential for laboratory models of disease and treatments for hearing loss and balance disorders.
Researchers found that Nanog is expressed similarly to other pluripotency markers, contradicting previous findings. This discovery could lead to reconsideration of the role of Nanog in differentiating embryonic stem cells.
Researchers at GIS and MPIMG discovered a molecular network in human embryonic stem cells that activates the ERK pathway, causing cells to respond by activating genetic information. The network also silences genetic information through ELK1, maintaining the cell's undifferentiated state.
Researchers have successfully transplanted human embryonic stem cells into monkeys with Parkinson's disease, demonstrating robust survival and integration of the cells. The study found that the gene expression of dopamine-producing neurons was transient after transplantation, highlighting the need for further research to optimize cell ...
Researchers have identified an unknown potassium channel in the cardiac pacemaker that regulates heartbeat. Developing therapies targeting this channel could bypass artificial pacemakers and provide biological solutions for arrhythmia.
Researchers at Mount Sinai have discovered a novel liver progenitor cell that can be differentiated from human embryonic stem cells and produce mature liver cells. This breakthrough discovery has the potential to revolutionize the treatment of liver disease, potentially overcoming the organ shortage issue.
Researchers at the University of Copenhagen's Danish Stem Cell Center have made a groundbreaking discovery in regressing embryonic stem cells to an early stage of development. This breakthrough could provide new insights into conditions such as miscarriages and placenta-related disorders.
Researchers at UCLA have isolated a new population of pluripotent stem cells, called Multi-lineage Stress-Enduring (Muse-AT) cells, from fat tissue that can differentiate into virtually every cell type in the human body. These cells are stress-resistant and may even be activated by severe stress, making them potentially superior source...
Scientists have developed a safety test for human induced pluripotent stem cells (iPS) that can identify unwanted cells forming tumours and assess cell stability. The breakthrough could improve the quality of iPS cells and lead to safer cell therapies.